Your browser doesn't support javascript.
loading
Correction to: A phase I-II study of plerixafor in combination with fludarabine, idarubicin, cytarabine, and G-CSF (PLERIFLAG regimen) for the treatment of patients with the first early-relapsed or refractory acute myeloid leukemia.
Martínez-Cuadrón, David; Boluda, Blanca; Martínez, Pilar; Bergua, Juan; Rodríguez-Veiga, Rebeca; Esteve, Jordi; Vives, Susana; Serrano, Josefina; Vidriales, Belen; Salamero, Olga; Cordón, Lourdes; Sempere, Amparo; Jiménez-Ubieto, Ana; Prieto-Delgado, Julio; Díaz-Beyá, Marina; Garrido, Ana; Benavente, Celina; Pérez-Simón, José Antonio; Moscardó, Federico; Sanz, Miguel A; Montesinos, Pau.
Afiliação
  • Martínez-Cuadrón D; Hematology Department, Hospital Universitari i Politècnic, La Fe, Avinguda Fernando Abril Martorell, 106, 46026, València, Spain.
  • Boluda B; CIBERONC, Instituto Carlos III, Madrid, Spain.
  • Martínez P; Hematology Department, Hospital Universitari i Politècnic, La Fe, Avinguda Fernando Abril Martorell, 106, 46026, València, Spain.
  • Bergua J; Hospital 12 de Octubre, Madrid, Spain.
  • Rodríguez-Veiga R; Hospital San Pedro de Alcántara, Cáceres, Spain.
  • Esteve J; Hematology Department, Hospital Universitari i Politècnic, La Fe, Avinguda Fernando Abril Martorell, 106, 46026, València, Spain.
  • Vives S; Hospital Clinic, Barcelona, Spain.
  • Serrano J; Hospital ICO-Universitari Germans Trias i Pujol, José Carreras, Leukemia Research Institute, Badalona, Spain.
  • Vidriales B; Hospital Reina Sofía, Córdoba, Spain.
  • Salamero O; Hospital Universitario de Salamanca, Salamanca, Spain.
  • Cordón L; Hospital Universitari Vall d'Hebron, Barcelona, Spain.
  • Sempere A; Hematology Department, Hospital Universitari i Politècnic, La Fe, Avinguda Fernando Abril Martorell, 106, 46026, València, Spain.
  • Jiménez-Ubieto A; CIBERONC, Instituto Carlos III, Madrid, Spain.
  • Prieto-Delgado J; Hematology Department, Hospital Universitari i Politècnic, La Fe, Avinguda Fernando Abril Martorell, 106, 46026, València, Spain.
  • Díaz-Beyá M; CIBERONC, Instituto Carlos III, Madrid, Spain.
  • Garrido A; Hospital 12 de Octubre, Madrid, Spain.
  • Benavente C; Hospital San Pedro de Alcántara, Cáceres, Spain.
  • Pérez-Simón JA; Hospital Clinic, Barcelona, Spain.
  • Moscardó F; Hospital de la Santa Creu i Sant Pau, Barcelona, Spain.
  • Sanz MA; Hospital Clínico San Carlos, Madrid, Spain.
  • Montesinos P; Hospital Universitario Virgen del Rocío, Sevilla, Spain.
Ann Hematol ; 97(5): 923, 2018 05.
Article em En | MEDLINE | ID: mdl-29473097
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Ano de publicação: 2018 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Ano de publicação: 2018 Tipo de documento: Article